166 related articles for article (PubMed ID: 33311477)
21. Cytoplasmic cyclin D1 regulates glioblastoma dissemination.
Cemeli T; Guasch-Vallés M; Nàger M; Felip I; Cambray S; Santacana M; Gatius S; Pedraza N; Dolcet X; Ferrezuelo F; Schuhmacher AJ; Herreros J; Garí E
J Pathol; 2019 Aug; 248(4):501-513. PubMed ID: 30957234
[TBL] [Abstract][Full Text] [Related]
22. CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells.
Maciaczyk D; Picard D; Zhao L; Koch K; Herrera-Rios D; Li G; Marquardt V; Pauck D; Hoerbelt T; Zhang W; Ouwens DM; Remke M; Jiang T; Steiger HJ; Maciaczyk J; Kahlert UD
Br J Cancer; 2017 Jun; 117(1):102-112. PubMed ID: 28571041
[TBL] [Abstract][Full Text] [Related]
23. miR‑96 inhibits EMT by targeting AEG‑1 in glioblastoma cancer cells.
Feng S; Yao J; Zhang Z; Zhang Y; Zhang Z; Liu J; Tan W; Sun C; Chen L; Yu X
Mol Med Rep; 2018 Feb; 17(2):2964-2972. PubMed ID: 29257267
[TBL] [Abstract][Full Text] [Related]
24. FOXC2 often overexpressed in glioblastoma enhances proliferation and invasion in glioblastoma cells.
Li W; Fu X; Liu R; Wu C; Bai J; Xu Y; Zhao Y; Xu Y
Oncol Res; 2013; 21(2):111-20. PubMed ID: 24406047
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
Guan Y; He Y; Lv S; Hou X; Li L; Song J
J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
[TBL] [Abstract][Full Text] [Related]
26. A novel splice variant of GLI1 that promotes glioblastoma cell migration and invasion.
Lo HW; Zhu H; Cao X; Aldrich A; Ali-Osman F
Cancer Res; 2009 Sep; 69(17):6790-8. PubMed ID: 19706761
[TBL] [Abstract][Full Text] [Related]
27. Annexin 2A sustains glioblastoma cell dissemination and proliferation.
Maule F; Bresolin S; Rampazzo E; Boso D; Della Puppa A; Esposito G; Porcù E; Mitola S; Lombardi G; Accordi B; Tumino M; Basso G; Persano L
Oncotarget; 2016 Aug; 7(34):54632-54649. PubMed ID: 27429043
[TBL] [Abstract][Full Text] [Related]
28. The embryonic type of SPP1 transcriptional regulation is re-activated in glioblastoma.
Kijewska M; Kocyk M; Kloss M; Stepniak K; Korwek Z; Polakowska R; Dabrowski M; Gieryng A; Wojtas B; Ciechomska IA; Kaminska B
Oncotarget; 2017 Mar; 8(10):16340-16355. PubMed ID: 28030801
[TBL] [Abstract][Full Text] [Related]
29. Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma.
Natsume A; Ito M; Katsushima K; Ohka F; Hatanaka A; Shinjo K; Sato S; Takahashi S; Ishikawa Y; Takeuchi I; Shimogawa H; Uesugi M; Okano H; Kim SU; Wakabayashi T; Issa JP; Sekido Y; Kondo Y
Cancer Res; 2013 Jul; 73(14):4559-70. PubMed ID: 23720055
[TBL] [Abstract][Full Text] [Related]
30. Sohlh1 suppresses glioblastoma cell proliferation, migration, and invasion by inhibition of Wnt/β-catenin signaling.
Liu X; Gao Q; Zhao N; Zhang X; Cui W; Sun J; Fu J; Hao J
Mol Carcinog; 2018 Apr; 57(4):494-502. PubMed ID: 29240260
[TBL] [Abstract][Full Text] [Related]
31. The gain-of-function GLI1 transcription factor TGLI1 enhances expression of VEGF-C and TEM7 to promote glioblastoma angiogenesis.
Carpenter RL; Paw I; Zhu H; Sirkisoon S; Xing F; Watabe K; Debinski W; Lo HW
Oncotarget; 2015 Sep; 6(26):22653-65. PubMed ID: 26093087
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.
Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y
Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288
[TBL] [Abstract][Full Text] [Related]
33. REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis.
Marisetty AL; Lu L; Veo BL; Liu B; Coarfa C; Kamal MM; Kassem DH; Irshad K; Lu Y; Gumin J; Henry V; Paulucci-Holthauzen A; Rao G; Baladandayuthapani V; Lang FF; Fuller GN; Majumder S
Neuro Oncol; 2019 Jun; 21(6):775-785. PubMed ID: 30953587
[TBL] [Abstract][Full Text] [Related]
34. Up-regulated circular RNA hsa_circ_0067934 contributes to glioblastoma progression through activating PI3K-AKT pathway.
Xin J; Zhang XY; Sun DK; Tian LQ; Xu P
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3447-3454. PubMed ID: 31081099
[TBL] [Abstract][Full Text] [Related]
35. CD99 Expression in Glioblastoma Molecular Subtypes and Role in Migration and Invasion.
Cardoso LC; Soares RDS; Laurentino TS; Lerario AM; Marie SKN; Oba-Shinjo SM
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845661
[TBL] [Abstract][Full Text] [Related]
36. RSK2 activity mediates glioblastoma invasiveness and is a potential target for new therapeutics.
Sulzmaier FJ; Young-Robbins S; Jiang P; Geerts D; Prechtl AM; Matter ML; Kesari S; Ramos JW
Oncotarget; 2016 Nov; 7(48):79869-79884. PubMed ID: 27829215
[TBL] [Abstract][Full Text] [Related]
37. Aberrant constitutive activation of nuclear factor kappaB in glioblastoma multiforme drives invasive phenotype.
Raychaudhuri B; Han Y; Lu T; Vogelbaum MA
J Neurooncol; 2007 Oct; 85(1):39-47. PubMed ID: 17479228
[TBL] [Abstract][Full Text] [Related]
38. miR-139-5p suppresses cancer cell migration and invasion through targeting ZEB1 and ZEB2 in GBM.
Yue S; Wang L; Zhang H; Min Y; Lou Y; Sun H; Jiang Y; Zhang W; Liang A; Guo Y; Chen P; Lv G; Wang L; Zong Q; Li Y
Tumour Biol; 2015 Sep; 36(9):6741-9. PubMed ID: 25833697
[TBL] [Abstract][Full Text] [Related]
39. Repression of Septin9 and Septin2 suppresses tumor growth of human glioblastoma cells.
Xu D; Liu A; Wang X; Chen Y; Shen Y; Tan Z; Qiu M
Cell Death Dis; 2018 May; 9(5):514. PubMed ID: 29724999
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide CRISPR/Cas9 screening identifies CARHSP1 responsible for radiation resistance in glioblastoma.
Zhu GD; Yu J; Sun ZY; Chen Y; Zheng HM; Lin ML; Ou-Yang S; Liu GL; Zhang JW; Shao FM
Cell Death Dis; 2021 Jul; 12(8):724. PubMed ID: 34290231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
